CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,955 | -23.6% | 8,647 | +4.7% | 0.00% | – |
| Q2 2023 | $10,410 | +115566.7% | 8,262 | +25.6% | 0.00% | – |
| Q1 2023 | $9 | -30.8% | 6,576 | -8.8% | 0.00% | -100.0% |
| Q4 2022 | $13 | -99.9% | 7,214 | +74.4% | 0.00% | – |
| Q3 2022 | $13,000 | +225.0% | 4,137 | +239.4% | 0.00% | – |
| Q2 2022 | $4,000 | – | 1,219 | +2157.4% | 0.00% | – |
| Q1 2022 | $0 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 1,935,215 | $6,270,000 | 5.97% |
| Sands Capital Ventures, LLC | 811,737 | $2,630,000 | 0.72% |
| Empirical Asset Management, LLC | 12,000 | $39,000 | 0.04% |
| Point72 Asset Management, L.P. | 743,082 | $2,408,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,700 | $430,000 | 0.01% |
| FRANKLIN RESOURCES INC | 1,125,000 | $3,645,000 | 0.00% |
| NORTHERN TRUST CORP | 14,483 | $47,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 75,217 | $243,000 | 0.00% |
| STATE STREET CORP | 27,600 | $89,000 | 0.00% |